Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases

© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This study aimed to identify factors that significantly influence the pharmacokinetics of voriconazole in Thai adults with hematologic diseases, and to determine optimal voriconazole dosing regimens. Blood samples were collected at steady sta...

Full description

Saved in:
Bibliographic Details
Main Authors: Buddharat Khan-Asa, Baralee Punyawudho, Noppaket Singkham, Piyawat Chaivichacharn, Ekapun Karoopongse, Methee Chayakulkeeree, Preecha Montakantikul
Format: Journal
Published: 2020
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090543166&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70185
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-70185
record_format dspace
spelling th-cmuir.6653943832-701852020-10-14T08:47:04Z Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases Buddharat Khan-Asa Baralee Punyawudho Noppaket Singkham Piyawat Chaivichacharn Ekapun Karoopongse Methee Chayakulkeeree Preecha Montakantikul Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine Pharmacology, Toxicology and Pharmaceutics © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This study aimed to identify factors that significantly influence the pharmacokinetics of voriconazole in Thai adults with hematologic diseases, and to determine optimal voriconazole dosing regimens. Blood samples were collected at steady state in 65 patients (237 concentrations) who were taking voriconazole to prevent or treat invasive aspergillosis. The data were analyzed using a nonlinear mixed-effects modeling approach. Monte Carlo simulation was applied to optimize dosage regimens. Data were fitted with the one-compartment model with first-order absorption and elimination. The apparent oral clearance (CL/F) was 3.43 L/h, the apparent volume of distribution (V/F) was 47.6 L, and the absorption rate constant (Ka) was fixed at 1.1 h−1 . Albumin and omeprazole ≥ 40 mg/day were found to significantly influence CL/F. The simulation produced the following recommended maintenance doses of voriconazole: 50, 100, and 200 mg every 12 h for albumin levels of 1.5–3, 3.01–4, and 4.01–4.5 g/dL, respectively, in patients who receive omeprazole ≤ 20 mg/day. Patients who receive omeprazole ≥ 40 mg/day and who have serum albumin level 1.5–3 and 3.01–4.5 g/dL should receive voriconazole 50 and 100 mg, every 12 h, respectively. Albumin level and omeprazole dosage should be carefully considered when determining the appropriate dosage of voriconazole in Thai patients. 2020-10-14T08:25:18Z 2020-10-14T08:25:18Z 2020-09-01 Journal 20796382 2-s2.0-85090543166 10.3390/antibiotics9090574 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090543166&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70185
institution Chiang Mai University
building Chiang Mai University Library
continent Asia
country Thailand
Thailand
content_provider Chiang Mai University Library
collection CMU Intellectual Repository
topic Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Pharmacology, Toxicology and Pharmaceutics
spellingShingle Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Pharmacology, Toxicology and Pharmaceutics
Buddharat Khan-Asa
Baralee Punyawudho
Noppaket Singkham
Piyawat Chaivichacharn
Ekapun Karoopongse
Methee Chayakulkeeree
Preecha Montakantikul
Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
description © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This study aimed to identify factors that significantly influence the pharmacokinetics of voriconazole in Thai adults with hematologic diseases, and to determine optimal voriconazole dosing regimens. Blood samples were collected at steady state in 65 patients (237 concentrations) who were taking voriconazole to prevent or treat invasive aspergillosis. The data were analyzed using a nonlinear mixed-effects modeling approach. Monte Carlo simulation was applied to optimize dosage regimens. Data were fitted with the one-compartment model with first-order absorption and elimination. The apparent oral clearance (CL/F) was 3.43 L/h, the apparent volume of distribution (V/F) was 47.6 L, and the absorption rate constant (Ka) was fixed at 1.1 h−1 . Albumin and omeprazole ≥ 40 mg/day were found to significantly influence CL/F. The simulation produced the following recommended maintenance doses of voriconazole: 50, 100, and 200 mg every 12 h for albumin levels of 1.5–3, 3.01–4, and 4.01–4.5 g/dL, respectively, in patients who receive omeprazole ≤ 20 mg/day. Patients who receive omeprazole ≥ 40 mg/day and who have serum albumin level 1.5–3 and 3.01–4.5 g/dL should receive voriconazole 50 and 100 mg, every 12 h, respectively. Albumin level and omeprazole dosage should be carefully considered when determining the appropriate dosage of voriconazole in Thai patients.
format Journal
author Buddharat Khan-Asa
Baralee Punyawudho
Noppaket Singkham
Piyawat Chaivichacharn
Ekapun Karoopongse
Methee Chayakulkeeree
Preecha Montakantikul
author_facet Buddharat Khan-Asa
Baralee Punyawudho
Noppaket Singkham
Piyawat Chaivichacharn
Ekapun Karoopongse
Methee Chayakulkeeree
Preecha Montakantikul
author_sort Buddharat Khan-Asa
title Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
title_short Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
title_full Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
title_fullStr Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
title_full_unstemmed Impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
title_sort impact of albumin and omeprazole on steady-state population pharmacokinetics of voriconazole and development of a voriconazole dosing optimization model in thai patients with hematologic diseases
publishDate 2020
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090543166&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70185
_version_ 1681752856642715648